• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺激素生成障碍及 基因突变患者的临床与分子研究。

Clinical and molecular study of patients with thyroid dyshormogenesis and variants in the gene.

机构信息

Growth and Development group, Vall d'Hebron Research Institute (VHIR), Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Centre for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.

出版信息

Front Endocrinol (Lausanne). 2024 Jul 8;15:1367808. doi: 10.3389/fendo.2024.1367808. eCollection 2024.

DOI:10.3389/fendo.2024.1367808
PMID:39040671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11260715/
Abstract

INTRODUCTION

Defects in any thyroid hormone synthesis steps cause thyroid dyshormonogenesis (THD). THD due to () gene variants is a cause of congenital hypothyroidism (CH) with a wide clinical spectrum, ranging from mild to severe permanent hypothyroidism. We present high-throughput sequencing results of patients with variants.

METHODS

A CH high-throughput sequencing-panel of the main genes involved in the regulation of thyroid hormonogenesis was performed to identify those variants that may be related to patient THD phenotype.

RESULTS

We identified 21 gene variants in 19 patients (11.8%) which could explain their phenotype. Ten of those (47.6%) were not previously described. CH was biochemically severe in these 19 patients. Eight of them were reevaluated after one month of discontinuing LT4 treatment and all had severe permanent hypothyroidism. We also identified another 16 patients who presented heterozygous variants, of whom, at reevaluation, five had mild permanent and only one had severe permanent hypothyroidisms.

DISCUSSIONS

In this study, 10 novel and 11 previously reported variants in the gene have been identified that could explain the phenotype of 19 patients from non-consanguineous families from a large THD cohort. Although not all these TG gene variants can explain all the patients' THD phenotypes, some of them had severe or mild permanent hypothyroidism at reevaluation.

摘要

简介

任何甲状腺激素合成步骤的缺陷都会导致甲状腺激素合成障碍(THD)。由于 ()基因变异导致的 THD 是先天性甲状腺功能减退症(CH)的一个原因,其临床表现广泛,从轻到重的永久性甲状腺功能减退症均有涉及。我们报告了患有 变异患者的高通量测序结果。

方法

对参与甲状腺激素生成调节的主要基因的 CH 高通量测序面板进行了检测,以确定可能与患者 THD 表型相关的 变异。

结果

我们在 19 名患者(11.8%)中发现了 21 种 基因变异,这些变异可以解释他们的表型。其中 10 种(47.6%)是以前没有描述过的。这些 19 名患者的 CH 在生化上都很严重。其中 8 名在停止 LT4 治疗一个月后重新评估,均患有严重的永久性甲状腺功能减退症。我们还发现了另外 16 名携带杂合 变异的患者,其中 5 名在重新评估时患有轻度永久性甲状腺功能减退症,只有 1 名患有严重永久性甲状腺功能减退症。

讨论

在这项研究中,我们在 19 名来自非近亲家庭的、表现出甲状腺激素合成障碍的大样本队列患者中,发现了 10 种新的和 11 种以前报道过的 基因变异,这些变异可以解释患者的表型。尽管并非所有这些 TG 基因变异都能解释所有患者的 THD 表型,但其中一些患者在重新评估时存在严重或轻度的永久性甲状腺功能减退症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3827/11260715/38f467b23074/fendo-15-1367808-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3827/11260715/38f467b23074/fendo-15-1367808-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3827/11260715/38f467b23074/fendo-15-1367808-g001.jpg

相似文献

1
Clinical and molecular study of patients with thyroid dyshormogenesis and variants in the gene.甲状腺激素生成障碍及 基因突变患者的临床与分子研究。
Front Endocrinol (Lausanne). 2024 Jul 8;15:1367808. doi: 10.3389/fendo.2024.1367808. eCollection 2024.
2
Genetic analyses in a cohort of Portuguese pediatric patients with congenital hypothyroidism.对一组患有先天性甲状腺功能减退症的葡萄牙儿科患者进行的基因分析。
J Pediatr Endocrinol Metab. 2019 Nov 26;32(11):1265-1273. doi: 10.1515/jpem-2019-0047.
3
Patients with Thyroid Dyshormonogenesis and Variants: Molecular and Clinical Description and Genotype-Phenotype Correlation.甲状腺激素生成障碍及变异患者:分子和临床描述以及基因型-表型相关性。
Int J Mol Sci. 2024 Aug 3;25(15):8473. doi: 10.3390/ijms25158473.
4
Genetics of Gland- or Hypoplastic Congenital Hypothyroidism in Macedonia.马其顿的腺体或发育不全性先天性甲状腺功能减退症的遗传学。
Front Endocrinol (Lausanne). 2020 Jul 14;11:413. doi: 10.3389/fendo.2020.00413. eCollection 2020.
5
Genotype-Phenotype Correlations in 30 Japanese Patients With Congenital Hypothyroidism Attributable to TG Defects.30例因甲状腺球蛋白缺陷导致先天性甲状腺功能减退症的日本患者的基因型-表型相关性
J Clin Endocrinol Metab. 2024 Aug 13;109(9):2358-2365. doi: 10.1210/clinem/dgae098.
6
Genetic Evaluation of Congenital Hypothyroidism with Gland Using Targeted Exome Sequencing.使用靶向外显子组测序对先天性甲状腺功能减退症的腺体进行遗传评估。
Ann Clin Lab Sci. 2021 Jan;51(1):73-81.
7
Screening of 23 candidate genes by next-generation sequencing of patients with permanent congenital hypothyroidism: novel variants in TG, TSHR, DUOX2, FOXE1, and SLC26A7.采用下一代测序技术对永久性先天性甲状腺功能减退症患者的 23 个候选基因进行筛查:TG、TSHR、DUOX2、FOXE1 和 SLC26A7 中的新型变异。
J Endocrinol Invest. 2022 Apr;45(4):773-786. doi: 10.1007/s40618-021-01706-1. Epub 2021 Nov 15.
8
The genetic characteristics of congenital hypothyroidism in China by comprehensive screening of 21 candidate genes.中国通过综合筛查 21 个候选基因对先天性甲状腺功能减退症的遗传特征进行研究。
Eur J Endocrinol. 2018 Jun;178(6):623-633. doi: 10.1530/EJE-17-1017. Epub 2018 Apr 12.
9
Molecular Analysis of Congenital Hypothyroidism in Saudi Arabia: SLC26A7 Mutation Is a Novel Defect in Thyroid Dyshormonogenesis.沙特阿拉伯先天性甲状腺功能减退症的分子分析:SLC26A7 突变是甲状腺激素生成障碍的新缺陷。
J Clin Endocrinol Metab. 2018 May 1;103(5):1889-1898. doi: 10.1210/jc.2017-02202.
10
Increased Prevalence of TG and TPO Mutations in Sudanese Children With Congenital Hypothyroidism.苏丹先天性甲状腺功能减退症儿童中 TG 和 TPO 突变的患病率增加。
J Clin Endocrinol Metab. 2020 May 1;105(5):1564-72. doi: 10.1210/clinem/dgz297.

引用本文的文献

1
A conserved acidic residue drives thyroxine synthesis within thyroglobulin and other protein precursors.一个保守的酸性残基驱动甲状腺球蛋白及其他蛋白质前体中的甲状腺素合成。
J Biol Chem. 2025 Jan;301(1):108026. doi: 10.1016/j.jbc.2024.108026. Epub 2024 Nov 26.

本文引用的文献

1
Congenital Hypothyroidism: Screening and Management.先天性甲状腺功能减退症:筛查与管理。
Pediatrics. 2023 Jan 1;151(1). doi: 10.1542/peds.2022-060420.
2
Approach to the Patient With Congenital Hypothyroidism.先天性甲状腺功能减退症患者的处理方法。
J Clin Endocrinol Metab. 2022 Nov 25;107(12):3418-3427. doi: 10.1210/clinem/dgac534.
3
Case Report: Expanding the Digenic Variants Involved in Thyroid Hormone Synthesis-10 New Cases of Congenital Hypothyroidism and a Literature Review.病例报告:扩展参与甲状腺激素合成的双基因变异——10例先天性甲状腺功能减退症新病例及文献综述
Front Genet. 2021 Aug 12;12:694683. doi: 10.3389/fgene.2021.694683. eCollection 2021.
4
Structure and genetic variants of thyroglobulin: Pathophysiological implications.甲状腺球蛋白的结构和遗传变异:病理生理意义。
Mol Cell Endocrinol. 2021 May 15;528:111227. doi: 10.1016/j.mce.2021.111227. Epub 2021 Mar 6.
5
New genetics in congenital hypothyroidism.先天性甲状腺功能减退症的新遗传学。
Endocrine. 2021 Mar;71(3):696-705. doi: 10.1007/s12020-021-02646-9. Epub 2021 Mar 1.
6
A novel mutation in intron 11 donor splice site, responsible of a rare genotype in thyroglobulin gene by altering the pre-mRNA splincing process. Cell expression and bioinformatic analysis.一种新的 11 号内含子供体位点突变,通过改变前体 mRNA 的剪接过程,导致甲状腺球蛋白基因中一种罕见的基因型。细胞表达和生物信息学分析。
Mol Cell Endocrinol. 2021 Feb 15;522:111124. doi: 10.1016/j.mce.2020.111124. Epub 2020 Dec 13.
7
Congenital Hypothyroidism: A 2020-2021 Consensus Guidelines Update-An ENDO-European Reference Network Initiative Endorsed by the European Society for Pediatric Endocrinology and the European Society for Endocrinology.先天性甲状腺功能减退症:2020-2021 年共识指南更新——一项由 ENDO-欧洲参考网络倡议发起并得到欧洲儿科内分泌学会和欧洲内分泌学会认可的倡议。
Thyroid. 2021 Mar;31(3):387-419. doi: 10.1089/thy.2020.0333.
8
Phenotypic Variability of Patients With PAX8 Variants Presenting With Congenital Hypothyroidism and Eutopic Thyroid.PAX8 变异患者伴发先天性甲状腺功能减退和甲状腺组织正常时的表型变异性。
J Clin Endocrinol Metab. 2021 Jan 1;106(1):e152-e170. doi: 10.1210/clinem/dgaa711.
9
Targeted Next-Generation Sequencing for Congenital Hypothyroidism With Positive Neonatal TSH Screening.新生儿促甲状腺激素筛查阳性的先天性甲状腺功能减退症的靶向新一代测序
J Clin Endocrinol Metab. 2020 Aug 1;105(8). doi: 10.1210/clinem/dgaa308.
10
The structure of human thyroglobulin.人甲状腺球蛋白的结构。
Nature. 2020 Feb;578(7796):627-630. doi: 10.1038/s41586-020-1995-4. Epub 2020 Feb 5.